NIH: Frequently Asked Questions

The National Institutes of Health operates as the primary federal biomedical research agency in the United States, funding more than $47 billion in research annually (NIH Budget FY2023, Office of Budget). Questions about how NIH functions — from grant classification and peer review to jurisdiction-specific compliance — arise constantly among researchers, institutions, patients, and policymakers. This page addresses the most common and substantive questions across those domains in plain, direct terms.

How does classification work in practice?

NIH organizes its funding and research activities through a structured taxonomy of mechanisms, institutes, and program designations. At the broadest level, NIH is divided into 27 institutes and centers, each with a defined scientific mission — for example, the National Cancer Institute focuses exclusively on oncology research, while the National Institute on Aging addresses aging science and age-related disease.

Within each institute, funding is classified by activity code. The R01 (Research Project Grant) is the most common investigator-initiated mechanism. K-series awards designate career development. F-series awards cover pre- and postdoctoral fellowships. T-series awards support institutional training programs. Each code carries distinct eligibility criteria, budget limits, and review standards. The NIH Grant Types and Mechanisms resource provides the full taxonomy.

Research itself is classified as either intramural — conducted by NIH-employed scientists at the agency's Bethesda, Maryland campus — or extramural, meaning funded at external universities, hospitals, and research organizations. The NIH Intramural vs. Extramural Research distinction affects everything from intellectual property rights to publication timelines.

What is typically involved in the process?

The NIH grant process follows a defined sequence that spans 9 to 12 months from submission to funding decision in most cases.

1. Opportunity identification — Applicants identify a Funding Opportunity Announcement (FOA) aligned with their research aims and the relevant institute's priorities.
2. Application preparation — A complete application includes specific aims, research strategy, biosketches, budget justification, human subjects protection documentation, and data management plans.
3. Submission — Applications are submitted through Grants.gov or ASSIST, with institutional sign-off from the applicant's Sponsored Programs Office.
4. Assignment — NIH assigns the application to a Scientific Review Group (SRG) and a primary funding institute or center.
5. Peer review — A study section evaluates the application and assigns a priority score, expressed as a percentile rank.
6. Advisory council review — The relevant institute's advisory council conducts a second-level review for funding recommendations.
7. Funding decision — The institute program officer makes the final determination, often based on the percentile rank cutoff (the "payline") for that fiscal year.

The NIH Grant Application Process and NIH Peer Review Process pages provide detailed procedural breakdowns.

What are the most common misconceptions?

Misconception 1: A high priority score guarantees funding. Peer review scores and percentile ranks are necessary but not sufficient. Institutes maintain paylines that fluctuate with the congressional appropriation. In years of budget constraint, even applications scoring in the 10th percentile may not receive funding.

Misconception 2: NIH funds clinical care. NIH funds research — including clinical trials — but does not reimburse patient care costs in routine healthcare settings. The NIH Clinical Center provides research-related care only within its own facility on the Bethesda campus.

Misconception 3: All NIH grants are the same. The R01 differs fundamentally from an SBIR/STTR award in eligibility, review criteria, and commercialization expectations. The NIH Small Business Grants (SBIR/STTR) program is specifically designed for small businesses, not academic investigators.

Misconception 4: Resubmissions are unlimited. NIH policy permits a maximum of one resubmission (A1) of a previously reviewed application. An A1 that fails review cannot be resubmitted in the same form.

Where can authoritative references be found?

The primary authoritative sources for NIH policy and data are official federal repositories:

• NIH Grants Policy Statement — Published by the NIH Office of Extramural Research, this document governs all terms and conditions of NIH awards (grants.nih.gov/policy).
• Code of Federal Regulations, Title 45, Part 46 — Governs the protection of human subjects in federally funded research (ecfr.gov).
• NIH Reporter — The publicly accessible database of all NIH-funded grants, searchable by investigator, institution, and keyword. The NIH Reporter Database page explains how to use this tool.
• PubMed — The NLM-maintained index of over 36 million biomedical literature citations. More information is available at NIH PubMed and Research Databases.
• MedlinePlus — The patient-facing health information resource maintained by NIH's National Library of Medicine (NIH MedlinePlus Health Information).

For regulatory history and the legislative framework authorizing NIH, the NIH Congressional Oversight and Authorization resource is the appropriate starting point.

How do requirements vary by jurisdiction or context?

NIH is a federal agency, and its core policies apply uniformly across all 50 states. However, the institutional environment in which grantees operate introduces significant variation.

State law governs issues such as stem cell research, controlled substance licensing for animal studies, and certain data privacy requirements that layer on top of federal standards. California, for instance, maintains the California Consumer Privacy Act, which affects how patient data from California residents may be handled even in federally funded studies.

International components of NIH-funded research trigger additional requirements under the Foreign Corrupt Practices Act and NIH's own policies on foreign components, which were significantly tightened following 2019 reports from the NIH Advisory Committee to the Director on foreign influence in research programs.

Subrecipient organizations — those receiving funds through a pass-through from a primary NIH grantee — must meet the same compliance standards as direct recipients, per 2 C.F.R. Part 200 (Uniform Guidance). The NIH Policies and Regulations page covers the compliance framework in full.

What triggers a formal review or action?

NIH and its oversight bodies initiate formal reviews under several defined circumstances:

• Programmatic review — Triggered when a grantee requests changes in scope, budget, or key personnel that exceed the thresholds specified in the Notice of Award.
• Audit findings — A Single Audit under the Uniform Guidance that flags material weaknesses or questioned costs will initiate a review by the NIH Division of Grants Compliance and Oversight.
• Human subjects concerns — Reports of unanticipated problems involving risks to participants, or findings from an institutional review board, must be reported to NIH within defined timeframes and may initiate a formal hold on research activities.
• Research misconduct — Allegations of fabrication, falsification, or plagiarism are processed through the Office of Research Integrity (ORI), which operates under the HHS Office of the Secretary rather than NIH directly. ORI maintains the authority to impose administrative actions, including debarment from federal funding for periods up to 10 years (ori.hhs.gov).
• Financial conflict of interest — Unreported or unmanaged financial interests trigger institutional and NIH review under 42 C.F.R. Part 50, Subpart F. The NIH Conflict of Interest Policy page details the disclosure thresholds.

How do qualified professionals approach this?

Experienced grant administrators and principal investigators treat NIH engagement as an ongoing institutional process rather than a series of discrete applications. Sponsored programs offices at research universities maintain dedicated pre-award and post-award teams who track regulatory changes through the NIH Guide for Grants and Contracts — the official weekly publication of funding opportunities and policy notices.

Principal investigators with sustained NIH funding typically maintain active relationships with program officers at relevant institutes, attending study section meetings as chartered or ad hoc reviewers to develop fluency in scoring criteria. Reviewer experience is documented to improve objectivity; NIH policy prohibits a reviewer from scoring an application with which they have a conflict of interest.

Fellowship and training applicants — including those exploring the NIH Training and Fellowship Programs and NIH Postdoctoral Programs — often work with mentors who have prior NIH review experience to calibrate application strategy to the specific study section assigned.

For detailed organizational context, the NIH Organizational Structure and NIH Director Role and Leadership pages clarify how decisions flow through the agency.

What should someone know before engaging?

The foundational resource for any entity considering NIH engagement is the home page of this reference site, which maps the full scope of NIH's structure, funding landscape, and compliance obligations. Before submitting any application, four elements require specific attention:

Institutional registration — The applicant organization must maintain active registrations in SAM.gov, Grants.gov, and the eRA Commons system. Each registration has independent renewal cycles; a lapsed registration will block submission regardless of application quality.

Indirect cost rates — Federally negotiated facilities and administrative (F&A) rates, established between each institution and its cognizant federal agency, determine how overhead is charged to NIH awards. Rates vary substantially — a major research university may negotiate rates above 55% of modified total direct costs, while a small nonprofit may negotiate below 20%.

Data sharing obligations — NIH's 2023 Data Management and Sharing Policy (NOT-OD-21-013) requires all applicants to submit a Data Management and Sharing Plan. Non-compliance is now a condition of award. The NIH Data Sharing Policy page covers the plan requirements.

Public access compliance — NIH requires that all peer-reviewed publications arising from NIH funding be made publicly available through PubMed Central within 12 months of publication, per the NIH Public Access Policy (NIH Open Access and Public Access Policy). Compliance is tracked and non-compliant investigators may be blocked from receiving new awards.